4//SEC Filing
Eaton Bruce 4
Accession 0001415889-22-011242
CIK 0001650664other
Filed
Nov 8, 7:00 PM ET
Accepted
Nov 9, 4:30 PM ET
Size
4.9 KB
Accession
0001415889-22-011242
Insider Transaction Report
Form 4
Eaton Bruce
EVP, Chief Business Officer
Transactions
- Sale
Common Stock
2022-11-08$11.02/sh−289$3,185→ 64,738 total
Footnotes (1)
- [F1]Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on November 6, 2022. The sale does not represent a discretionary trade by the Reporting Person.
Documents
Issuer
Editas Medicine, Inc.
CIK 0001650664
Entity typeother
Related Parties
1- filerCIK 0001874831
Filing Metadata
- Form type
- 4
- Filed
- Nov 8, 7:00 PM ET
- Accepted
- Nov 9, 4:30 PM ET
- Size
- 4.9 KB